Get to know the API Board of Directors.
Mr Richard Vincent (CEO & Managing Director)
Richard was appointed CEO and Managing Director in February 2017. Mr Vincent started his professional career in finance with Bridgestone before moving to Britax Rainsfords where he was CFO. He joined FH Faulding & Co Limited in 1998 and remained with that company until 2005, during which time he held a number of senior leadership roles, including responsibility for the pharmacy distribution, retail merchandise and generic pharmaceutical development. He joined API in 2005 where he has held a number of General Manager roles that have included pharmacy business development, strategy, supply chain, franchise recruitment, IT, manufacturing and M & A. Richard is the Deputy Chairman of the National Pharmaceutical Services Associationand was also a director of CH2 from 2006 to 2015. Richard has a Bachelor of Business (Accountancy) and is a Certified Practising Accountant.
Mr Peter R Robinson (Chairman)
B.Com, FAICD, Non-Executive Director

Director since 5 May 2000

Appointed Chairman 8 July 2003

Mr Robinson has held both executive and non-executive directorships for over 30 years. Mr Robinson also during this time has had extensive general management and chief executive officer experience in the pharmaceutical industry.

Other current listed company directorships:

  • Clover Corporation Limited
  • TPI Enterprises Ltd (listed ASX 10 August 2015)

Former listed company directorships in the past three years:

  • Washington H Soul Pattinson and Company Limited (appointed 1984, resigned 31 March 2015)
  • New Hope Corporation Limited (appointed August 1997, resigned 31 March 2015)
  • Exco Resources Limited (appointed November 2012, company de-listed January 2013)
Mr Robert D Millner
FAICD, Non-Executive Director

Director since 5 May 2000

Appointed Member of the Remuneration Committee on 2 October 2007

Appointed Member of the Nomination Committee on 15 August 2012

Mr Millner has had extensive management and public company experience across a number of industries.

Other current listed company directorships:

  • Brickworks Limited
  • BKI Investment Company Limited
  • Milton Corporation Limited
  • New Hope Corporation Limited
  • TPG Telecom Ltd
  • Washington H Soul Pattinson and Company Limted

Former listed company directorships in the past three years:

  • Exco Resources Limited (appointed November 2012, company de-listed January 2013)
Ms Lee Ausburn
M.Pharm, B.Pharm, Dip.Hosp.Pharm, GAICD Independent Non-Executive Director

Director since 7 October 2008

Appointed member of the Audit and Risk Committee on 7 October 2008

Appointed member of the Nomination Committee on 15 August 2012 and appointed Chair on 8 April 2015

Ms Ausburn is a pharmacist with experience in retail and hospital pharmacy and in academia. She had a long career in the pharmaceutical industry with Merck Sharp and Dohme (Australia) Pty Ltd and was previously Vice President, Asia, for Merck and Co Inc with responsibility for the company’s operations across Asia.

Ms Ausburn is also President, Pharmacy Faculty Foundation, University of Sydney and is a former board member of the Clinical Excellence Commission and Agency for Clinical Innovation, NSW Health.

Other current listed company directorships:

  • NIB Holdings Limited
  • Somnomed Limited
Mr Gerard J Masters
Independent Non-Executive Director

Director since 7 September 2010

Appointed Member of the Nomination Committee on 15 August 2012

Appointed Member and Chair of the Remuneration Committee on 30 January 2014

Mr Masters has had extensive experience in retailing. Until his resignation in early 2006, he spent more than 33 years with the Coles Myer Group. This included a 10 year period as Managing Director of Bi Lo, Coles and then the total Supermarkets Group which was Coles Myer’s largest and most profitable business. His most recent role, until his resignation in 2009, was as the Managing Director and CEO of The Reject Shop Limited.

Mr Kenneth W Gunderson-Briggs
B. Bus, FCA, MAICD, Senior Independent Non-Executive Director

Director since 6 May 2014

Appointed Member of the Audit and Risk Committee on 6 May 2014 and appointed Chair on 25 January 2017

Appointed Member of the Remuneration Committee on 8 April 2015

Appointed Senior Independent Director 2 September 2015

Mr Gunderson-Briggs is a Chartered Accountant, Registered Company Auditor and Public Company Director, with broad experience in the finance and retail franchise sectors.

Mr Gunderson-Briggs has been Chairman of Glenaeon Rudolf Steiner School Limited since 2013, having been a Director on the Board since 2009.

Other current listed company directorships:

  • Harvey Norman Holdings Limited